The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Re­call re­port: No­vo Nordisk re­calls sam­ples of mul­ti­ple in­sulin prod­ucts af­ter stor­age screw-up

4 years ago
FDA+

In the lat­est chap­ter of Emer­gent saga, CEO Bob Kramer will ad­dress US House sub­com­mit­tee on plant woes

4 years ago
Coronavirus

Covid-19 man­u­fac­tur­ing roundup: Emer­gent starts clean-up ef­fort af­ter dis­as­trous Form 483; Eli Lil­ly ex­pands li­cens­es for In­di­an part­ners

4 years ago
Coronavirus

A clos­er look at the FDA’s more than 700 pan­dem­ic-re­lat­ed record re­quests to re­place on­site in­spec­tions

4 years ago
FDA+

BioN­Tech ex­pands mR­NA man­u­fac­tur­ing to Sin­ga­pore as clam­or for Covid-19 vac­cine and boost­ers swells

5 years ago

Q&A: Ain­drea Camp­bell goes small, step­ping away from Ap­ple to head man­u­fac­tur­ing at Zymer­gen — where am­bi­tions are big

5 years ago
People
Outsourcing

Gold­man Sachs jumps aboard Bain-backed 503(b) com­pound­ing phar­ma­cy with a $275M debt loan to sup­ply hos­pi­tals

5 years ago
Financing
Outsourcing

Lon­za keeps adding on as it looks to beef up bi­o­log­ics of­fer­ing, tack­ing on near­ly $1B in ex­pan­sions in EU, US

5 years ago
Outsourcing

An­oth­er Mod­er­na ex­pan­sion is an­nounced, this time at its Mass­a­chu­setts site

5 years ago

Catal­ent snaps up Promether­a's cell ther­a­py sub­sidiary, com­plete with a Bel­gian plant to help scale plas­mid DNA ef­forts

5 years ago
Outsourcing

Mod­er­na CEO brush­es off US sup­port for IP waiv­er, eyes more than $19B in Covid-19 vac­cine sales in 2021

5 years ago
Coronavirus

Re­call re­port: Acel­la pulls thy­roid tablets af­ter a raft of side ef­fect re­ports; mis­la­bel­ing caus­es Pfiz­er's Hos­pi­ra to yank 2 lots of anes­thet­ics

5 years ago
FDA+

Biden ad­min­is­tra­tion backs a po­lar­iz­ing pro­pos­al to waive IP for all Covid-19 vac­cines

5 years ago
Pharma
FDA+

Covid-19 man­u­fac­tur­ing roundup: Freez­er kits to store vac­cines de­liv­ered to Venezuela; UN chief weighs in on IP de­bate

5 years ago
Outsourcing
Coronavirus

Al­ta­sciences, true to its word, ex­pands its foot­print with ac­qui­si­tion of Penn­syl­va­nia CRO

5 years ago
Deals

Fo­cused on the cell ther­a­py man­u­fac­tur­ing bot­tle­neck, Cel­lares tur­bocharges plans for 'shut­tle' tech

5 years ago
Financing
Cell/Gene Tx

Emer­gent reshuf­fles its man­u­fac­tur­ing brain trust as CEO sends mixed mes­sages around Covid-19 vac­cine de­ba­cle

5 years ago
Coronavirus

Covid-19 man­u­fac­tur­ing roundup: Catal­ent adds freez­er part­ner for vac­cine pro­duc­tion push; In need of vol­un­teers, Lon­za turns to food work­ers

5 years ago
Coronavirus

AskBio bails on in-li­censed gene ther­a­py pro­gram af­ter find­ing is­sues with 3rd-par­ty man­u­fac­tur­er

5 years ago
R&D

Sam­sung Bi­o­log­ics, TG Ther­a­peu­tics ink deal to mass pro­duce MS hope­ful ubli­tux­imab

5 years ago
Outsourcing

Ther­mo Fish­er has flour­ished amid the pan­dem­ic, but can it keep the ball rolling when Covid-19 comes to a close?

5 years ago
Outsourcing

Sanofi is ex­pand­ing at light speed abroad, but it's leav­ing be­hind a Penn­syl­va­nia plant and its 75 em­ploy­ees

5 years ago
Pharma

Forge Bi­o­log­ics bags $120M round as it looks to scale AAV man­u­fac­tur­ing for Krabbe dis­ease treat­ment

5 years ago
Financing

Lon­za adds on small mol­e­cule fa­cil­i­ty at Visp site, adding new weight to its ex­pan­sion plans on the back of a big year

5 years ago
Outsourcing
First page Previous page 71727374757677 Next page Last page
A service from the Financial Times